Allergies News and Research

Latest Allergies News and Research

Tulane University to receive $11.2M over seven years to establish international malaria research center

Tulane University will receive approximately $11.2 million over seven years from the National Institute of Allergy and Infectious Diseases, a division of the National Institutes of Health, to establish an International Center of Excellence in Malaria Research for West and Central Africa. The money will be awarded in response to a multi-institutional proposal from Tulane University School of Public Health and Tropical Medicine.

9 Jul 2010

NIAID announces $14M in first-year funding to establish 10 new malaria research centers

In an effort to accelerate the control of malaria and help eliminate it worldwide, the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, today announced approximately $14 million in first-year funding to establish 10 new malaria research centers around the world.

9 Jul 2010

UC San Diego professor to establish new Peru/Brazil ICEMR to help control malaria

Tropical disease specialist Joseph Vinetz, MD, of the University of California, San Diego School of Medicine will lead an ambitious multi-national effort to help control and eventually conquer malaria, establishing a new Peruvian/Brazilian International Center of Excellence in Malaria Research Center with a seven-year, $9.2 million grant from the National Institutes of Health.

9 Jul 2010

Accudial's weight-based rotating labels prevent underdosing and overdosing in children's OTC medications

There is plenty to worry about when it comes to the job of parenting. However, wondering if a child is receiving the correct amount of over-the-counter (OTC) medication can now be a concern of the past, thanks to Children's AccuDial(R), a patented new line of children's medication available across Canada, with a dosing system based on body weight, not age.

9 Jul 2010

MSU-led research team to create new malaria prevention, control strategies in Malawi with $9.1M federal grant

As part of a continued effort to eliminate the scourge of malaria in the southern African nation of Malawi, a Michigan State University-led research team will use a $9.1 million federal grant to create new prevention and control strategies in the small, landlocked country.

9 Jul 2010

Media outlets examine efforts to tackle HIV/AIDS worldwide

Ahead of the International AIDS Conference, set for July 18-23 in Vienna, Austria, Reuters features an interview with Gottfried Hirnschall, the new director of the WHO's HIV Department, who speaks of the need for current funds for the global HIV/AIDS programs to be used more efficiently to achieve universal access to treatment for all HIV/AIDS patients.

9 Jul 2010

PharmAthene reports progress in lyophilized rPA anthrax vaccine development program

PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that it continues to make solid progress in its lyophilized recombinant Protective Antigen (rPA) anthrax vaccine development program. The Company has recently demonstrated that its lyophilized rPA vaccine candidate is structurally stable and potent at various temperatures up to and including 70 degrees centigrade.

9 Jul 2010

FDA-approved bioidentical estrogens help women manage common symptoms of menopause

Women looking for the best method to manage common symptoms of menopause, like hot flashes and night sweats, may not have access to credible information, especially when it comes to understanding their estrogen therapy options. In fact, there are an array of celebrities and authors who are simply not qualified to give medical advice about managing menopause, yet they dominate the internet and media space simply because of their popularity.

8 Jul 2010

Codex Alimentarius Commission provides new guidance to help improve food safety

The maximum amount of melamine allowed in powdered infant formula is 1 mg/kg and the amount of the chemical allowed in other foods and animal feed is 2.5 mg/kg, according to new rulings from the United Nations' food standards body, Codex Alimentarius Commission.

7 Jul 2010

FDA accepts DBV Technologies' IND for clinical study of VIASKIN for desensitization to peanut allergy

DBV Technologies (DBV), a biotech company specializing in food allergy with innovative products for diagnosis and treatment, announced today the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application. DBV Technologies will begin clinical investigation of its lead food allergy desensitization candidate, VIASKIN® PEANUT, for the desensitization to peanut allergy. The Company expects to commence recruitment of peanut allergy patients at several medical centers in the U.S. this month.

7 Jul 2010

Caraco Pharmaceutical Laboratories commences shipping azelastine ophthalmic solution

Caraco Pharmaceutical Laboratories, Ltd. has started shipping azelastine ophthalmic solution, 0.05%. This product was recently approved by the US Food and Drug Administration (FDA) for Sun Pharma's Abbreviated New Drug Application (ANDA).

7 Jul 2010

Further analysis on Bcl11b gene and T-cell behaviouur from Caltech Biologists

When does a cell decide its particular identity? According to biologists at the California Institute of Technology (Caltech), in the case of T cells-immune system cells that help destroy invading pathogens-the answer is when the cells begin expressing a particular gene called Bcl11b.

3 Jul 2010

FDA issues consumer update on safety alerts

The Food and Drug Administration (FDA) has issued safety alerts about a number of products.

3 Jul 2010

OTA reminds consumers to choose organic foods over synthetic dye foods

In response to a call from the Center for Science in the Public Interest (CSPI) to ban synthetic dyes to color foods, the Organic Trade Association (OTA) today reminded consumers that they can already avoid such dyes in the marketplace by choosing to purchase organic foods.

2 Jul 2010

UCLA study highlights traffic-related asthma flares in urban areas

A new academic study led by UCLA scientists has found that even brief exposure to ultrafine pollution particles near a Los Angeles freeway is potent enough to boost the allergic inflammation that exacerbates asthma.

2 Jul 2010

Mutations in Siglec-8 gene may play role in asthma: Research

A gene that encodes a protein responsible for determining whether certain immune cells live or die shows subtle differences in some people with asthma, a team led by Johns Hopkins researchers reports in the June European Journal of Human Genetics.

1 Jul 2010

Sepracor announces preliminary results from OMNARIS HFA Phase III study for seasonal allergic rhinitis

Sepracor Inc. announced today the preliminary results of a large-scale, 671-patient Phase III study of OMNARIS® (ciclesonide) HFA, an aerosol nasal formulation of ciclesonide, for the treatment of seasonal allergic rhinitis (SAR) in adult and adolescent patients. In this study, OMNARIS HFA met its primary efficacy endpoint by demonstrating a statistically significant reduction versus placebo in the reflective total nasal symptom score averaged over a two-week treatment period.

1 Jul 2010

Bortezomib may offer hope for treating inflammatory diseases: New research

Those looking for a new treatment for a range of inflammatory diseases like arthritis, multiple sclerosis, inflammatory bowel disease, and lupus may need to look no further than a drug already available for treating cancer. In a research report published in the July 2010 print issue of the Journal of Leukocyte Biology, Japanese scientists use mice to show that bortezomib, currently used to treat cancers that affect white blood cells, induces cell death only in harmful (active and proliferating) T cells, leaving the rest unharmed.

1 Jul 2010

AdVnt launches 15 Minute Black Mold Detection Test

AdVnt Biotechnologies, the company known for producing BioWarfare Agent Detection Devices for HAZMAT First Response Teams around the globe to help them rapidly detect such biological agents as Anthrax, Ricin and Botulinum, has just released its newest product for In-Home and Professional use. Building on the expertise gained in the international arena of BioWarfare Agent Detection, AdVnt is now applying its R&D expertise to help defend against another type of bio threat that could be growing in the walls and under the floorboards in your own home.

30 Jun 2010

Gene diagnosis to be featured at 9th INT'L BIO FORUM & BIO EXPO JAPAN

9th INT'L BIO FORUM & BIO EXPO JAPAN, organized by Reed Exhibitions Japan, will come back again as Asia's largest bio-event from June 30 - July 2, 2010. "Gene diagnosis" is one of the featured topics for this year.

30 Jun 2010

Allergies News and Research

Latest Allergies News and Research

Tulane University to receive $11.2M over seven years to establish international malaria research center

NIAID announces $14M in first-year funding to establish 10 new malaria research centers

UC San Diego professor to establish new Peru/Brazil ICEMR to help control malaria

Accudial's weight-based rotating labels prevent underdosing and overdosing in children's OTC medications

MSU-led research team to create new malaria prevention, control strategies in Malawi with $9.1M federal grant

Media outlets examine efforts to tackle HIV/AIDS worldwide

PharmAthene reports progress in lyophilized rPA anthrax vaccine development program

FDA-approved bioidentical estrogens help women manage common symptoms of menopause

Codex Alimentarius Commission provides new guidance to help improve food safety

FDA accepts DBV Technologies' IND for clinical study of VIASKIN for desensitization to peanut allergy

Caraco Pharmaceutical Laboratories commences shipping azelastine ophthalmic solution

Further analysis on Bcl11b gene and T-cell behaviouur from Caltech Biologists

FDA issues consumer update on safety alerts

OTA reminds consumers to choose organic foods over synthetic dye foods

UCLA study highlights traffic-related asthma flares in urban areas

Mutations in Siglec-8 gene may play role in asthma: Research

Sepracor announces preliminary results from OMNARIS HFA Phase III study for seasonal allergic rhinitis

Bortezomib may offer hope for treating inflammatory diseases: New research

AdVnt launches 15 Minute Black Mold Detection Test

Gene diagnosis to be featured at 9th INT'L BIO FORUM & BIO EXPO JAPAN

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Allergies News and Research

Latest Allergies News and Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in